FDA inspection
Astra Zeneca (Medimmune Pharma B.V.): FDA inspection ending Sep 22, 2017
FDA inspection 1036241 · Nijmegen
Key facts
| Inspection ID | 1036241 |
|---|---|
| Firm | Astra Zeneca (Medimmune Pharma B.V.) |
| FEI number | 3003000472 |
| Address | Lagelandseweg 78 |
| City | Nijmegen |
| Fiscal year | 2017 |
| Inspection end date | Sep 22, 2017 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data